EVMN

Evommune, Inc.

NYSE · Healthcare

$12.66

-4.63% today

last filing 2026-06-22Pro sees filings in ~15 min

Price

hover · 4 moves explained

5 buys9 sells4 8-K

Analyst consensus

Buy

$31.14target+146.0%vs $12.66 today

$22.00 low today target$54.00 high

7 analysts · ~12-month consensus · as of Jul 6. Relayed analyst opinion, which tends to run optimistic — not our forecast or advice.

Earnings

Beat 1 of last 2

Earnings per share · actual vs forecast

Q3 '25+28.9%

−$8.07

exp −$11.36

Q4 '25-69.8%

−$1.43

exp −$0.84

Type	Date	Insider	Title	Of stake	Shares	Price	Value
Sell	2026-06-24	Drew Janice Suzann	Chief of Dev. Operations	—Direct	20,000	$22.63	$452.6K
Exercise	2026-06-24	Drew Janice Suzann	Chief of Dev. Operations	—Direct	16,161	$2.99	$48.3K
Exercise	2026-06-24	Drew Janice Suzann	Chief of Dev. Operations	—Direct	3,839	$3.84	$14.7K
Sell	2026-06-24	Patel Jeegar Pravinkumar	Chief Scientific Officer	—Direct	1,488	$22.50	$33.5K
Exercise	2026-06-24	Patel Jeegar Pravinkumar	Chief Scientific Officer	—Direct	1,488	$3.84	$5.7K

Sell

Drew Janice Suzann

Chief of Dev. Operations · 2026-06-24

$452.6K

20,000 @ $22.63

Exercise

Drew Janice Suzann

Chief of Dev. Operations · 2026-06-24

$48.3K

16,161 @ $2.99

Exercise

Drew Janice Suzann

Chief of Dev. Operations · 2026-06-24

$14.7K

3,839 @ $3.84

Sell

Patel Jeegar Pravinkumar

Chief Scientific Officer · 2026-06-24

$33.5K

1,488 @ $22.50

Exercise

Patel Jeegar Pravinkumar

Chief Scientific Officer · 2026-06-24

$5.7K

1,488 @ $3.84

42 more transactions on ProFull insider transaction history is a Pro feature.

Upgrade →